IMAI Medtech provides an automated 3D histology platform that prepares fully stained tissue samples within hours instead of weeks. The system integrates rapid clearing, high‑resolution light‑sheet imaging, and quantitative analysis software to improve cancer detection accuracy. By reducing false negatives and streamlining workflow, it lowers diagnostic costs and supports faster clinical decision‑making.
Funding
$220K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional 2D histology methods can lead to information loss and false negatives in cancer detection due to their limited ability to visualize the full tissue structure. Manual tissue staining and processing are also time-consuming, often taking weeks to complete.
Solution
IMAI MedTech offers an automated 3D histology platform that accelerates tissue staining and processing, reducing the preparation time from weeks to hours. The platform provides detailed 3D visualization and quantitative analysis of tissue samples, enhancing diagnostic accuracy in cancer detection. By leveraging advanced detection technologies, the platform significantly reduces false negatives, leading to more accurate diagnoses and improved patient outcomes. The system's automation and precision contribute to a higher cell detection rate and more comprehensive examination of tissue characteristics.
Target Audience
The primary customers are researchers, cancer diagnostic centers, and healthcare providers seeking to improve the speed and accuracy of tissue analysis for cancer detection.
Features
- Automated tissue staining and clearing protocols for rapid 3D histology
- Compatibility with light-sheet microscopy for high-resolution 3D imaging
- Advanced image analysis software for efficient 3D sample interaction and visualization
- Quantitative analysis of tissue structures and cellular arrangements
- Automated and precise methodologies to ensure a higher cell detection rate
- Potential to improve treatment outcomes through early and precise cancer cell detection